Penumbra (PEN) Cash & Current Investments (2014 - 2026)

Penumbra (PEN) reported Cash & Current Investments of $615.7 million for Q1 2026, up 62.51% year-over-year from $378.8 million in Q1 2025, and up 13.0% quarter-over-quarter from $544.8 million in Q4 2025.

Penumbra (PEN) Cash & Current Investments (2014 - 2026) Analysis & Trends

Penumbra (PEN) has 13 years of Cash & Current Investments data on file, last reported at $615.7 million in Q1 2026.

  • Cash & Current Investments for Q1 2026 came in at $615.7 million, up 62.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $615.7 million (up 62.51% YoY), and the FY2025 annual result was $544.8 million, up 60.18% from the prior year.
  • Cash & Current Investments climbed to $615.7 million in Q1 2026 per PEN's latest filing, from $544.8 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $615.7 million in Q1 2026 and troughed at $184.4 million in Q3 2022.
  • A 5-year average of $323.2 million and a median of $291.0 million in 2024 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2022 and 2026: Cash & Current Investments slumped 30.91% in 2022, then surged 62.51% in 2026.
  • A 5-year view of Cash & Current Investments shows it stood at $188.0 million in 2022, then surged by 53.8% to $289.2 million in 2023, then gained by 17.62% to $340.1 million in 2024, then soared by 60.18% to $544.8 million in 2025, then gained by 13.0% to $615.7 million in 2026.
  • Business Quant data shows PEN's Cash & Current Investments at $615.7 million in Q1 2026, $544.8 million in Q4 2025, and $470.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 7.30 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 2.88 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 8.38 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 3.67 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 2.29 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.12 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 1.12 Bn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 439.60 Mn
10 Penumbra 12.51 Bn 11.90 Bn 253.41 Mn 615.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 615.66 Mn
Dec 31, 2025 544.82 Mn
Sep 30, 2025 470.30 Mn
Jun 30, 2025 424.56 Mn
Mar 31, 2025 378.85 Mn
Dec 31, 2024 340.13 Mn
Sep 30, 2024 291.02 Mn
Jun 30, 2024 339.70 Mn
Mar 31, 2024 313.47 Mn
Dec 31, 2023 289.19 Mn
Sep 30, 2023 248.86 Mn
Jun 30, 2023 221.06 Mn
Mar 31, 2023 199.10 Mn
Dec 31, 2022 188.03 Mn
Sep 30, 2022 184.43 Mn
Jun 30, 2022 204.37 Mn
Mar 31, 2022 240.34 Mn
Dec 31, 2021 254.88 Mn
Sep 30, 2021 266.93 Mn
Jun 30, 2021 156.72 Mn